Published in Women's Health Weekly, August 1st, 2002
The doctors work at the University of Padova in Italy, where they compared the effects of delivering angiostatin, endostatin, and IFN-alpha(1) with at least two human breast cancer cell lines (MCF7 and MDA-MB435) using Moloney leukemia virus-based retroviral vectors. Each type of transferred gene is known to convey angiogenic inhibition when delivered to cells in gene therapy.
Initially, S. Indraccolo and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.